CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells.

These results demonstrated that circ_0004585 played an oncogenic role during PCa invasion and metastasis by targeting the miR-1248/TM9SF4 axis while providing new insight into therapeutic strategy development for metastatic PCa.